Anew MedicalGRMLWPreferred / convertible

13F holders, Q2 2025 (June 30)
7holders −12
2new positions
14sold out
1famous investor
$0.24avg. 13F price*

At the end of Q2 2025, 7 institutions reported holding Anew Medical Inc. (GRMLW) in their 13F filings, down 12 from Q1 2025. 2 opened new positions and 14 sold out. The largest holders were Aristeia Capital, L.L.C. ($266K), D. E. Shaw & Co. ($72K) and Clear Street LLC ($14K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Anew Medical Inc.
Filed as
KLOTHO NEUROSCIENCES INC (Q2 2025)
CUSIP
49876K111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q3 2024: 22Q3 2024Q4 2024: 22Q4 2024Q1 2025: 19Q1 2025Q2 2025: 7Q2 2025Q3 2025: 6Q3 2025Q4 2025: 7Q4 2025Q1 2026: 5Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions2$5K
Exits14$248K

All 13F filers, Q1 2025 → Q2 2025: 524,743 shares bought and 5,060,103 shares sold, net −4,535,360 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

Aristeia Capital, L.L.C. — Add +83.7% 1,106,754 $266K
D. E. Shaw & Co. — No change 300,000 $72K
Clear Street LLC — Reduce -80.8% 54,202 $14K
Warberg Asset Management LLC — New 10,100 $3K
OneDigital Investment Advisors LLC — New 10,000 $2K
UBS Group AG — Add +26.9% 666 $167
Bank of America Corp. — Add +81.3% 223 $56

"% of holder's portfolio" is GRMLW's weight in each manager's 13F, not the share of Anew Medical Inc. the manager owns.